Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Rises By 72.0%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 62,100 shares, an increase of 72.0% from the February 28th total of 36,100 shares. Based on an average daily volume of 1,440,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.2% of the company’s shares are short sold.

Biodexa Pharmaceuticals Stock Down 4.7 %

Biodexa Pharmaceuticals stock traded down $0.06 during mid-day trading on Friday, hitting $1.23. The company’s stock had a trading volume of 81,220 shares, compared to its average volume of 500,861. The business has a 50 day moving average of $3.39. Biodexa Pharmaceuticals has a 12 month low of $1.23 and a 12 month high of $74.00.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.